Carboplatin-allergic patients undergoing desensitization: prevalence and impact of the BRCA 1/2 mutation

J Allergy Clin Immunol Pract. 2017 May-Jun;5(3):816-818. doi: 10.1016/j.jaip.2016.08.012. Epub 2016 Oct 17.

¹ Division of Rheumatology, Immunology and Allergy, Department of Medicine, Brigham and Women's Hospital, Boston, Mass; Division of Clinical Immunology and Allergy, University of São Paulo Medical School, São Paulo, Brazil.
² Division of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, Tenn; Institute for Immunology and Infectious diseases, Murdoch University, Perth, Australia.
³ Division of Clinical Immunology and Allergy, University of São Paulo Medical School, São Paulo, Brazil.
⁴ Division of Rheumatology, Immunology and Allergy, Department of Medicine, Brigham and Women's Hospital, Boston, Mass. Electronic address: mcastells@partners.org.

No abstract available

Publication types